KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) EPS (Basic): 2009-2025

Historic EPS (Basic) for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to -$0.21.

  • Neogenomics' EPS (Basic) fell 50.00% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.88, marking a year-over-year decrease of 44.26%. This contributed to the annual value of -$0.62 for FY2024, which is 11.43% up from last year.
  • Per Neogenomics' latest filing, its EPS (Basic) stood at -$0.21 for Q3 2025, which was up 40.00% from -$0.35 recorded in Q2 2025.
  • Neogenomics' 5-year EPS (Basic) high stood at $0.64 for Q2 2021, and its period low was -$0.40 during Q1 2022.
  • Its 3-year average for EPS (Basic) is -$0.19, with a median of -$0.19 in 2023.
  • Examining YoY changes over the last 5 years, Neogenomics' EPS (Basic) showed a top increase of 1,166.67% in 2021 and a maximum decrease of 950.00% in 2021.
  • Neogenomics' EPS (Basic) (Quarterly) stood at -$0.35 in 2021, then spiked by 48.57% to -$0.18 in 2022, then surged by 38.89% to -$0.11 in 2023, then declined by 9.09% to -$0.12 in 2024, then tumbled by 50.00% to -$0.21 in 2025.
  • Its EPS (Basic) stands at -$0.21 for Q3 2025, versus -$0.35 for Q2 2025 and -$0.20 for Q1 2025.